Basics |
Embecta Corp.
|
IPO Date: |
April 1, 2022 |
Sector: |
Healthcare |
Industry: |
Drug Manufacturers - Specialty and Generic |
Market Cap: |
$586.76M |
Activated in VL: |
True |
Average Daily Range |
Avg Daily Range: |
$0.45 | 2.18%
|
Avg Daily Range (30 D): |
$0.34 | 2.91%
|
Avg Daily Range (90 D): |
$0.34 | 2.68%
|
Institutional Daily Volume |
Avg Daily Volume: |
.47M |
Avg Daily Volume (30 D): |
.53M |
Avg Daily Volume (90 D): |
.46M |
Trade Size |
Avg Trade Size (Sh.): |
61 |
Avg Trade Size (Sh.) (30 D): |
62 |
Avg Trade Size (Sh.) (90 D): |
59 |
Institutional Trades |
Total Inst.Trades: |
1,301 |
Avg Inst. Trade: |
$2.28M |
Avg Inst. Trade (30 D): |
$1.57M |
Avg Inst. Trade (90 D): |
$1.54M |
Avg Inst. Trade Volume: |
.1M |
Avg Inst. Trades (Per Day): |
1 |
Market Closing Trades |
Avg Closing Trade: |
$2.56M |
Avg Closing Trade (30 D): |
$1.56M |
Avg Closing Trade (90 D): |
$1.6M |
Avg Closing Volume: |
114.2K |
|
|
Financials |
|
TTM |
Q1 2025 |
Q4 2024 |
Basic EPS
|
$.4
|
$
|
$.25
|
Diluted EPS
|
$.4
|
$
|
$.24
|
Revenue
|
$ 259M
|
$ 261.9M
|
$ 286.1M
|
Gross Profit
|
$ 164.1M
|
$ 157.1M
|
$ 173.8M
|
Net Income / Loss
|
$ 23.5M
|
$ M
|
$ 14.6M
|
Operating Income / Loss
|
$ 62.9M
|
$ 28.7M
|
$ 26.2M
|
Cost of Revenue
|
$ 94.9M
|
$ 104.8M
|
$ 112.3M
|
Net Cash Flow
|
$
|
$
|
$ -10M
|
PE Ratio
|
24.43
|
|
|
|
|
|